Introduction
Introduction

3-iodothyronamine (T1AM) is a novel endogenously synthesized relative of thyroid hormone with significant physiological and behavioural effects in mammals
. In isolated rat hearts micromolar concentrations of T1AM produced a reversible, dose-dependent negative inotropic and chronotropic effect [1, 2] . In cultured rat cardiomyocytes decreased cellular shortening and increased action potential duration were reported upon exposure to T1AM [2] . These actions occur within minutes and consequently they appear to represent a non-genomic [3, 4] . Messenger RNAs coding for at least five different TAAR subtypes are expressed in rat heart and it has been suggested that one or more TAAR subtypes mediate T1AM's diverse biological effects [2] . There 
response. Interestingly, T1AM does not interact with nuclear thyroid hormone receptors. Rather in vitro it can activate heterologously expressed cloned rodent and human trace amine associated receptor 1 (TAAR1), and possibly other members of the same family of G-protein coupled receptors
is convincing evidence that transduction of T1AM-stimulated signalling involves changes in the phosphorylation state of tyrosine residues in yet-to-be-determined proteins, but the final effectors responsible for the functional effects have not been determined. Because myocardial function is largely dependent on the modulation of ionic currents and requires an adequate supply of metabolic energy, the present study attempted to understand T1AM's effects on myocardial metabolism and ionic homeostasis.
Modulation of cardiac ionic homeostasis by 3-iodothyronamine
Sandra
Isolated heart perfusion
This investigation conforms to the Declaration of Helsinki and the Guiding Principles in the Care and Use of Animals. The project was approved by the Animal Care and Use committee of the University of Pisa. Male Wistar rats (275-300 g body weight)
, fed a standard diet, were anesthetized with a mixture of ether and air. The heart was then quickly excised and perfused according to the working heart technique, as described previously [2] . The height of the atrial chamber was set at 20 cm, corresponding to a filling pressure of 15 mmHg. To measure oxygen consumption the pulmonary artery was cannulated and samples of perfusate were collected from the aortic and pulmonary cannulas without exposure to air, as described previously [6] . Glucose was assayed in the recirculating perfusion buffer by the glucose oxidase technique using a commercial Glucose Assay Kit , and the rate of glucose uptake was calculated by linear regression.
Cardiomyocyte experiments
Left ventricular cardiomyocytes were prepared from male Wistar rat hearts by enzymatic digestion in a Langendorff apparatus. The isolated cells were resuspended in Tyrode's solution, as described previously [7] . [9] . The techniques to assay SR function, previously described and validated [9] [10] [11] 
Results
Functional and metabolic effects
Electrophysiological effects
The electrophysiological effects of T1AM were studied in adult ventricular cardiomyocytes using the whole-cell patch-clamp technique. On the basis of our isolated heart results we decided to use 20 M T1AM. T1AM had no effect on peak density of calcium currents but affected ICa-L inactivation kinetics (Fig. 1) [14, 15] . This is illustrated in Fig. 1A : under control conditions, the current evoked from a holding potential of -45 mV was Ϸ30% greater than that evoked from a holding potential of -75 mV. T1AM completely abolished this phenomenon because the currents measured at -45 and -75 mV had the same amplitude (Fig. 1B) . The steady state inactivation (Fig. 4) , revealed peak amplitude to be significantly reduced after exposure to T1AM at 20 mV to at 50 mV (n ϭ 5, P Ͻ 0.05 in each case).
Fig. 2 Effect of 20 M T1AM on calcium transients in rat ventricular cardiomyocytes. T1AM (red trace) reduced the decay time and area of calcium transients with respect to control (black trace). See text for cumulative results obtained in eight different preparations. not reach statistical significance. The activation curve of Ito current, obtained by plotting maximal Ito density versus step potential
Effects on SR function
To investigate whether the observed modifications of the calcium transient are associated with changes in SR function we determined the effects of perfusing with 20 M T1AM on ryanodine binding, SR calcium release and oxalate-supported calcium uptake.
Ryanodine is a selective ligand of the SR calcium release channels and changes in ryanodine binding provide indirect evidence of changes in channel structure or gating [17] . Saturation binding curves obtained in control hearts and in hearts perfused with T1AM are shown in Fig. 5 (left 
nM). Incubation of control SR vesicles with 20
M T1AM did not affect ryanodine binding (Fig. 5, right panel) , demonstrating the observed effect was not due to direct interaction of T1AM with the SR calcium channel. Fig. 6 [9, 12] . As shown in Fig. 7, at [1, 2, 18] . Several functional effects of T1AM have already been described, and the focus of the present work was to unravel the molecular mechanism underlying its effects on contractility and action potential duration.
In other experiments SR vesicles obtained from hearts which had been perfused with T1AM were loaded with radiolabelled calcium and the kinetics of calcium induced calcium release were determined by a quick filtration technique, using a buffer containing 18 M unlabelled calcium to determine full channel activation. As shown in the left panel of
Discussion
T1AM is a recently identified, naturally occurring compound that is most likely derived in vivo from thyroid hormone through decarboxylation and deiodination. In vitro evidence suggests T1AM activates a novel aminergic system coupled to the so-called TAARs
In the isolated rat heart a negative inotropic response to T1AM was observed before any decrease in oxygen consumption or glucose uptake is produced. Therefore [15] . While facilitation may be also favoured by L-channel phosphorylation by protein kinase A [15] [20, 21] . This phenomenon is known as autoregulation, and it has been argued that modulation of calcium-induced calcium release cannot produce persistent changes in calcium transients, while the latter are largely dependent on the total SR calcium content [21] . The latter is determined by the difference between active uptake by the SR calcium-ATPase and diastolic calcium leak [19] [2] . Interestingly, tyrosine kinases and tyrosine phosphatases are known to modulate ionic channels in several cell types, including the heart, possibly by modulating the subcellular distribution of channel proteins and/or their association with ancillary proteins [24, 25] . In the current context it would be particularly interesting to assess whether T1AM can influence the interaction of the ryanodine receptor with FKBP12, a protein thought to regulate the diastolic calcium leak [19] . [2] . Changes in local T1AM concentration might contribute to the cardiac manifestations of thyroid disease, and might be involved in pathological conditions such as heart failure, in which the role of thyroid hormone is certainly relevant but remains to be comprehensively clarified [26, 27] . In any case pharmacological manipulation of this interesting new signalling system could provide an exciting new approach to modulating cardiac function.
potentials (-50 and -30 mV), was abolished. Facilitation has generally been attributed to L-channel modulation by SR calcium release and is impaired after depletion of SR-sequestered calcium
